Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Salivary Gland Neoplasms × Sunitinib × Clear all

Sponsor

Conditions

Carcinoma, Renal Cell 56 Breast Neoplasms 19 Kidney Neoplasms 16 Gastrointestinal Stromal Tumors 14 Neoplasms 12 Carcinoma, Non-Small-Cell Lung 9 Prostatic Neoplasms 8 Urinary Bladder Neoplasms 7 Neoplasm Metastasis 6 Colorectal Neoplasms 6 Brain Neoplasms 5 Thyroid Neoplasms 4 Stomach Neoplasms 4 Small Cell Lung Carcinoma 4 Ovarian Neoplasms 4 Neuroendocrine Tumors 4 Liver Neoplasms 4 Carcinoma, Hepatocellular 4 Carcinoma 4 Thyroid Cancer, Papillary 3 Sarcoma 3 Leukemia, Myelomonocytic, Chronic 3 Kidney Diseases 3 Glioblastoma 3 Esophageal Neoplasms 3 Clear-cell metastatic renal cell carcinoma 3 Astrocytoma 3 Adenoma, Islet Cell 3 Adenocarcinoma, Follicular 3 Urogenital Neoplasms 2

Interventions

Cetuximab 3 Vorinostat 2 Radiosurgery 2 Nivolumab 2 Ipilimumab 2 Dasatinib 2 Cisplatin 2 Bevacizumab 2 temsirolimus 1 pembrolizumab 1 ispinesib 1 eribulin 1 dehydroftorafur 1 apalutamide 1 alectinib 1 Sorafenib 1 Sirolimus 1 Platinum 1 Pilocarpine 1 Oral Hygiene 1 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 1 Moxibustion 1 Magnetic Resonance Spectroscopy 1 MK 2206 1 Lapatinib 1 Irinotecan 1 Immunoglobulin G 1 Gonadotropin-Releasing Hormone 1 Gemcitabine 1 Gefitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡